226 related articles for article (PubMed ID: 29304563)
1. The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG
Solbeck S; Jensen AS; Maschmann C; Stensballe J; Ostrowski SR; Johansson PI
Scand J Clin Lab Invest; 2018; 78(1-2):25-30. PubMed ID: 29304563
[TBL] [Abstract][Full Text] [Related]
2. Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests.
Solbeck S; Ostrowski SR; Stensballe J; Johansson PI
Int J Cardiol; 2016 Apr; 208():14-8. PubMed ID: 26826624
[TBL] [Abstract][Full Text] [Related]
3. On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation.
Skeppholm M; Hjemdahl P; Antovic JP; Muhrbeck J; Eintrei J; Rönquist-Nii Y; Pohanka A; Beck O; Malmström RE
Thromb Res; 2014 Oct; 134(4):783-9. PubMed ID: 25172669
[TBL] [Abstract][Full Text] [Related]
4. [Monitoring of Oral Thrombin Inhibitor].
Matsuno K; Usami T; Hatuse M; Shimizu C
Rinsho Byori; 2014 Oct; 62(10):958-64. PubMed ID: 27526541
[TBL] [Abstract][Full Text] [Related]
5. Impact of dabigatran on platelet function and fibrinolysis.
Tsantes AE; Kyriakou E; Bonovas S; Chondrogianni M; Zompola C; Liantinioti C; Simitsi A; Katsanos AH; Atta M; Ikonomidis I; Kapsimali V; Kopterides P; Tsivgoulis G
J Neurol Sci; 2015 Oct; 357(1-2):204-8. PubMed ID: 26219486
[TBL] [Abstract][Full Text] [Related]
6. The assessment of anticoagulant activity to predict bleeding outcome in atrial fibrillation patients receiving dabigatran etexilate.
Chang YT; Hu YF; Liao JN; Chern CM; Lin YJ; Chang SL; Wu CH; Sung SH; Wang KL; Lu TM; Chao TF; Lo LW; Hsu LC; Chung CP; Chang PM; Hsu WH; Chiou CW; Chen SA
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):389-95. PubMed ID: 26991859
[TBL] [Abstract][Full Text] [Related]
7. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
[TBL] [Abstract][Full Text] [Related]
8. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.
Bliden KP; Chaudhary R; Mohammed N; Muresan AA; Lopez-Espina CG; Cohen E; Raviv G; Doubleday M; Zaman F; Mathew B; Tantry US; Gurbel PA
J Thromb Thrombolysis; 2017 May; 43(4):437-445. PubMed ID: 28247290
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of dabigatran therapy using Hemoclot(®) Thrombin Inhibitor assay in patients with atrial fibrillation.
Samoš M; Stančiaková L; Ivanková J; Staško J; Kovář F; Dobrotová M; Galajda P; Kubisz P; Mokáň M
J Thromb Thrombolysis; 2015 Jan; 39(1):95-100. PubMed ID: 25103614
[TBL] [Abstract][Full Text] [Related]
10. Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
Douxfils J; Lessire S; Dincq AS; Hjemdahl P; Rönquist-Nii Y; Pohanka A; Gourdin M; Chatelain B; Dogné JM; Mullier F
Thromb Haemost; 2015 Apr; 113(4):862-9. PubMed ID: 25519251
[TBL] [Abstract][Full Text] [Related]
11. Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting Assay: A Prospective, Single-Arm, Open-Label Study.
Fong AYY; Tiong LL; Tan SSN; Geruka D; Apil GG; Choo CW; Ong TK
Clin Appl Thromb Hemost; 2020; 26():1076029620972473. PubMed ID: 33284050
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures.
Pipilis A; Makrygiannis S; Anagnostou G; Kaliampakos S; Tsakonas G; Sourlas N; Mallios P; Kostelidou T
J Thromb Thrombolysis; 2017 Jul; 44(1):9-13. PubMed ID: 28488236
[TBL] [Abstract][Full Text] [Related]
13. Impact of Dabigatran Treatment on Rotation Thromboelastometry.
Sokol J; Nehaj F; Ivankova J; Mokan M; Zolkova J; Lisa L; Linekova L; Mokan M; Stasko J
Clin Appl Thromb Hemost; 2021; 27():1076029620983902. PubMed ID: 33523711
[TBL] [Abstract][Full Text] [Related]
14. Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
Silva VM; Scanavacca M; Darrieux F; Cavalheiro C; Strunz CC
Clin Appl Thromb Hemost; 2019; 25():1076029619835053. PubMed ID: 30907118
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography.
Solbeck S; Meyer MA; Johansson PI; Meyer AS; Cotton BA; Stensballe J; Schött U; Ostrowski SR
Int J Cardiol; 2014 Oct; 176(3):794-9. PubMed ID: 25156858
[TBL] [Abstract][Full Text] [Related]
16. Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods.
Du S; Weiss C; Christina G; Krämer S; Wehling M; Krämer R; Harenberg J
Clin Chem Lab Med; 2015 Jul; 53(8):1237-47. PubMed ID: 25720084
[TBL] [Abstract][Full Text] [Related]
17. Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.
Taune V; Skeppholm M; Ågren A; Gryfelt G; Malmström RE; Wikman A; Van Ryn J; Wallén H
J Thromb Haemost; 2018 Dec; 16(12):2462-2470. PubMed ID: 30288934
[TBL] [Abstract][Full Text] [Related]
18. Relation between dabigatran concentration, as assessed using the direct thrombin inhibitor assay, and activated clotting time/activated partial thromboplastin time in patients with atrial fibrillation.
Okubo K; Kuwahara T; Takagi K; Takigawa M; Nakajima J; Watari Y; Nakashima E; Yamao K; Fujino T; Tsutsui H; Takahashi A
Am J Cardiol; 2015 Jun; 115(12):1696-9. PubMed ID: 25918026
[TBL] [Abstract][Full Text] [Related]
19. Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000.
Artang R; Brod C; Nielsen JD
Semin Thromb Hemost; 2022 Oct; 48(7):808-813. PubMed ID: 36174600
[TBL] [Abstract][Full Text] [Related]
20. Laboratory assessment of the anticoagulant activity of dabigatran.
Kyriakou E; Ikonomidis I; Stylos D; Bonovas S; Papadakis I; Nikolopoulos GK; Kokoris S; Kalantzis D; Economopoulou C; Kopterides P; Lekakis J; Tsantes AE
Clin Appl Thromb Hemost; 2015 Jul; 21(5):434-45. PubMed ID: 25525048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
